TAS2R31 is a bitter taste receptor encoded by the TAS2R31 gene in primates, including Gorilla gorilla gorilla (western lowland gorilla). It belongs to the T2R family of taste receptors, which are G-protein-coupled receptors (GPCRs) involved in detecting bitter compounds to deter harmful substances . In humans, TAS2R31 is known to respond to saccharin in vitro and is expressed in airway smooth muscle, where its activation induces bronchodilation via calcium-dependent potassium channel opening .
The recombinant TAS2R31 protein is produced in E. coli with an N-terminal His tag for purification. Key features include:
Form: Lyophilized powder in Tris/PBS-based buffer with 6% trehalose (pH 8.0) .
Storage:
Reconstitution: Recommended in deionized sterile water (0.1–1.0 mg/mL) with glycerol for stability .
Limited Functional Data: Most research focuses on human TAS2R31; gorilla-specific studies are needed to confirm ligand specificity and physiological roles.
Synthetic Applications: Recombinant TAS2R31 may aid in developing bitter taste modulators or diagnostic tools for metabolic disorders linked to TAS2R signaling .
TAS2R31 belongs to the type 2 taste receptor family (TAS2Rs), which comprises G protein-coupled receptors that recognize compounds perceived as bitter to humans and aversive to vertebrates. These receptors initiate bitter taste perception by triggering depolarization of taste bud cells . TAS2R31 is also known by alternative names including T2R31 and T2R44, and it belongs to a five-member subfamily (TAS2R30-46) that responds to a diverse constellation of compounds .
In the context of functional studies, TAS2R31 has been identified as an agonist responsive to artificial sweeteners with bitter aftertastes, including saccharin and acesulfame K . The receptor is expressed not only in gustatory tissues but also in several non-gustatory tissues including lung, trachea, ovary, ganglia, and brain, suggesting broader physiological functions beyond taste perception .
For functional expression of TAS2R proteins, including TAS2R31, heterologous expression systems utilizing human embryonic kidney 293 (HEK293) cells have proven effective in numerous studies . When expressing recombinant TAS2R31, researchers typically employ the following methodology:
Design expression vectors containing the TAS2R31 coding sequence with appropriate epitope tags for detection and purification
Transiently or stably transfect mammalian cell lines, particularly HEK293 cells
Co-express necessary signaling components such as G-proteins (typically Gα16gust44, a chimeric G-protein)
Validate expression through Western blotting, immunofluorescence, or functional calcium mobilization assays
For gorilla TAS2R31 specifically, researchers may need to optimize codon usage for mammalian expression and consider the inclusion of chaperone proteins to enhance proper folding and membrane targeting .
For characterizing the ligand specificity of recombinant gorilla TAS2R31, researchers should consider the following functional assays:
Calcium Flux Assays: The most widely used method involves detecting intracellular calcium release following receptor activation. This approach requires:
Transfection of cells with gorilla TAS2R31 and appropriate G-protein constructs
Loading cells with calcium-sensitive fluorescent dyes (e.g., Fluo-4 AM)
Measuring fluorescence changes upon ligand application using plate readers or fluorescence microscopy
Analyzing dose-response relationships to determine EC50 values for various bitter compounds
cAMP Accumulation Assays: As an alternative to calcium measurements, researchers can quantify changes in cyclic AMP levels following receptor activation.
Receptor Internalization Assays: Monitoring receptor trafficking using fluorescently tagged TAS2R31 can provide insights into receptor dynamics following ligand binding.
Molecular Docking and Mutagenesis: Combining computational docking with site-directed mutagenesis can identify key residues involved in ligand recognition. This approach has been successful with human TAS2R31 variants .
A cross-species comparison between human and gorilla TAS2R31 responses to known bitter compounds can reveal evolutionary adaptations in bitter taste perception relevant to dietary specialization.
To investigate tissue-specific expression patterns of TAS2R31 in gorilla samples, researchers should implement a multi-method approach:
RNA Analysis:
RT-qPCR using TAS2R31-specific primers designed based on the gorilla sequence
RNA-seq analysis of various tissues to obtain comprehensive expression profiles
In situ hybridization to visualize tissue and cellular localization
Protein Detection:
Immunohistochemistry using antibodies validated for cross-reactivity with gorilla TAS2R31
Western blotting of tissue lysates
Immunofluorescence microscopy for subcellular localization
Reporter Systems:
For in vivo models, Cre-mediated recombination approaches similar to those used in mouse studies can be adapted . This involves:
Generating TAS2R31-specific Cre knock-in constructs
Using binary genetic approaches with fluorescent reporters to visualize TAS2R31-expressing cells
Tracking expression during developmental stages
Based on human and mouse studies, researchers should examine both gustatory tissues (tongue, palate) and non-gustatory tissues including respiratory tract (lung, trachea), reproductive tissues (ovary), neural tissues (ganglia, brain), and digestive organs .
Several genetic engineering approaches can be employed to study TAS2R31 function:
CRISPR-Cas9 Gene Editing:
Generate knockout cell lines to study loss-of-function effects
Introduce specific mutations identified in gorilla TAS2R31 into human cell lines
Create knock-in reporter lines to track receptor expression and trafficking
Cre-Lox Recombination Systems:
Inducible Expression Systems:
Tetracycline-controlled or other inducible promoters to regulate TAS2R31 expression
This approach allows temporal control of receptor expression for developmental studies
Chimeric Receptor Approaches:
Generate chimeric receptors between gorilla and human TAS2R31 to identify domains responsible for differential ligand recognition
Swap specific transmembrane domains or extra/intracellular loops to map functional regions
These approaches enable detailed investigation of gorilla TAS2R31 function, potentially revealing unique adaptations in bitter taste perception related to dietary specialization in gorillas.
Functional variations in TAS2R31 across great apes, including gorillas, likely reflect evolutionary adaptations to diverse ecological niches and dietary preferences:
Polymorphism Analysis:
Human TAS2R genes exhibit extensive polymorphism, with numerous nonsynonymous variants affecting receptor function . Analysis of gorilla TAS2R31 should examine:
Selection Pressure Analysis:
Studies of human TAS2R genes have found evidence suggesting relaxation of selective pressure in recent human evolution . Researchers should examine:
Ratios of nonsynonymous to synonymous substitutions (dN/dS) in gorilla TAS2R31
Population-specific selection signatures using statistics like Tajima's D
Fixation index (FST) values to assess differentiation between populations
Comparative Functional Studies:
Ecological Correlation:
Researchers should investigate correlations between TAS2R31 variants and:
Known bitter compounds in species-specific diets
Potential toxic plant compounds encountered in natural habitats
Dietary specialization and food preference behaviors
This evolutionary perspective provides insight into how variations in TAS2R31 might contribute to adaptive responses to environmental challenges faced by different great ape species.
Producing high-yield, functional recombinant gorilla TAS2R31 presents several technical challenges:
Membrane Protein Expression Issues:
As a G protein-coupled receptor, TAS2R31 contains multiple transmembrane domains that complicate proper folding and trafficking
Low expression levels are common with bitter taste receptors
Potential solution: Use specialized expression vectors with strong promoters and optimization of codon usage for the expression system
Protein Solubility and Stability:
Membrane proteins are inherently difficult to solubilize while maintaining native conformation
Researchers should evaluate multiple detergents or nanodiscs for optimal solubilization
Consider fusion partners that enhance solubility (e.g., MBP, SUMO)
Post-translational Modifications:
Ensure the expression system provides appropriate glycosylation and other modifications
Mammalian expression systems are preferable over bacterial systems for this reason
Functional Verification:
Cross-reactivity issues present significant challenges when studying TAS2R31 across primate species:
Antibody Development and Validation:
Develop antibodies against conserved epitopes across primate TAS2R31 orthologs
Rigorously validate antibody specificity using:
Western blots with recombinant proteins from multiple species
Immunoprecipitation followed by mass spectrometry
Immunofluorescence with appropriate knockout controls
Primer and Probe Design for Nucleic Acid Detection:
Design primers targeting conserved regions for cross-species amplification
Validate amplification specificity using sequencing
Consider species-specific probes for quantitative applications
Ligand Specificity Assessment:
Test a panel of known human TAS2R31 ligands against recombinant gorilla TAS2R31
Generate dose-response curves to identify differences in potency or efficacy
Create a comparative pharmacological profile across species
Computational Approaches:
Homology modeling to predict structural differences that might affect ligand binding
Molecular docking simulations to predict cross-species differences in ligand interactions
Sequence alignment tools to identify conserved functional domains
Based on information available for recombinant proteins similar to TAS2R31, the following storage and handling conditions are recommended:
Storage Buffer Composition:
Temperature Considerations:
Handling Recommendations:
Minimize exposure to light, particularly for fluorescently tagged constructs
Perform manipulations at 4°C when possible
Consider addition of reducing agents (e.g., DTT) to prevent oxidation of cysteine residues
Quality Control:
Regularly assess protein integrity via SDS-PAGE
Verify functionality using established ligand-binding or signaling assays
Monitor for aggregation using dynamic light scattering or size-exclusion chromatography
For comprehensive analysis of TAS2R31 sequence variations across primates, researchers should employ the following bioinformatic approaches:
Sequence Alignment and Phylogenetic Analysis:
Multiple sequence alignment using tools like MUSCLE or CLUSTAL
Construction of phylogenetic trees to visualize evolutionary relationships
Analysis of selection pressures using methods like PAML
Variation Identification and Classification:
Structural Analysis:
Homology modeling based on GPCR crystal structures
Identification of conserved functional domains
Prediction of transmembrane regions and binding pockets
Molecular dynamics simulations to assess effects of variants
Population Genetics Metrics:
These approaches will provide a comprehensive understanding of evolutionary patterns in TAS2R31 across primates and identify potentially functionally significant variations.
When interpreting differences in ligand response profiles between human and gorilla TAS2R31, researchers should consider:
Pharmacological Parameter Comparison:
Compare EC50 values (potency) for shared ligands
Assess maximum response (efficacy) differences
Evaluate differences in activation thresholds
Analyze kinetics of receptor activation and desensitization
Structure-Function Relationship Analysis:
Correlate sequence differences with altered ligand responses
Identify key amino acid residues responsible for species-specific responses
Consider the role of specific domains (e.g., transmembrane regions, extracellular loops)
Ecological and Evolutionary Context:
Relate differences to dietary specialization of gorillas versus humans
Consider potential toxic compounds encountered in natural habitats
Evaluate whether differences reflect adaptations or genetic drift
Functional Redundancy Considerations:
Assess overlap in ligand specificity with other TAS2R family members
Consider compensatory mechanisms that might exist in vivo
Evaluate the net effect on bitter taste perception in the context of the complete receptor repertoire
Translational Implications:
Consider how identified differences might inform understanding of human taste perception
Evaluate potential implications for non-gustatory functions of TAS2R31 in tissues like airways and gut
Assess whether findings provide insight into therapeutic targeting of bitter taste receptors
Several emerging technologies hold promise for advancing our understanding of gorilla TAS2R31 function:
Organoid Models:
Development of tongue and taste bud organoids from gorilla stem cells
Co-culture systems that recapitulate taste receptor cell microenvironments
Application of single-cell transcriptomics to characterize cell populations
Advanced Imaging Techniques:
Super-resolution microscopy for subcellular localization
FRET/BRET sensors to monitor receptor activation in real time
Light-sheet microscopy for 3D visualization in tissue contexts
Biosensor Development:
GPCR-based biosensors that report TAS2R31 activation via fluorescence or luminescence
Cell-based assays with improved sensitivity and throughput
Microfluidic systems for rapid screening of potential ligands
Animal Models with Humanized or Gorilla TAS2R31:
Computational Approaches:
Advanced machine learning for predicting ligand-receptor interactions
Systems biology models integrating TAS2R31 signaling with downstream pathways
In silico evolution models to predict adaptive changes
Understanding gorilla TAS2R31 function can make significant contributions to comparative physiology research in several key areas:
Evolutionary Adaptations in Sensory Systems:
Provide insights into how taste perception systems evolved in response to dietary specialization
Reveal mechanisms of sensory adaptation in diverse ecological niches
Contribute to understanding the evolution of food preference behaviors
Extra-oral Functions of Taste Receptors:
Research in humans and mice has revealed TAS2R expression in non-gustatory tissues including lung, trachea, ovary, ganglia, and brain
Comparative studies may reveal conserved or divergent functions of TAS2R31 in these tissues
Potential roles in innate immunity, respiratory function, and other physiological systems
Structure-Function Relationships in GPCRs:
Cross-species comparisons can identify critical residues and domains for TAS2R31 function
Reveal principles of ligand recognition that extend to other G protein-coupled receptors
Illuminate mechanisms of receptor activation and signal transduction
Dietary Ecology and Plant-Animal Interactions:
Connect molecular adaptations in TAS2R31 to feeding behaviors and food selection
Provide insights into co-evolutionary relationships between plants producing bitter compounds and primate consumers
Enhance understanding of dietary adaptations in great ape evolution
Biomedical Applications:
Potential for identifying novel ligands with therapeutic applications
Understanding mechanisms of bitter taste perception relevant to medication compliance
Insights into non-gustatory functions of TAS2Rs that may have clinical relevance